Life Sciences and Transformational Health

  The   Botulinum Toxin Market Share  is estimated to run through a   CAGR of 7.7%   between   2026 , reaching   US$ US$ 8 Billion . Online services have made a beeline to almost every industry vertical. The healthcare vertical is at the forefront herein. With e-prescriptions and door-to-door delivery of medicines taking over, 100% digital adoption is not far. It’s, in fact, not just a need but a necessity herein. It won’t be incorrect to state that the “Out-Patient Department” would be the “Online Patient Department” in the future. This would simplify the surgical processes as well, as the healthcare practitioners would be able to prioritize the course of treatment. Whether it is a 40+ woman worried about the wrinkles and fine lines on her skin or a patient suffering from chronic migraines and excessive sweating, the whole world swears by  botulinum toxin  as the ultimate go-to remedy that promises instant and long-lasting relief. Botulinum ...

  The   Wound Cleanser Products Market Share  is to grow at a   CAGR of 0.015   between   2021-2031   and reach   US$ US$ 2.4 Bn . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Wound cleanser products are known to remove contaminants and foreign materials such as debris on the skin surrounding the wound and the surface of the wound, and come in solutions, sprays, gels, and wipes. These cleansers are an effective means of infection control and help in preventing hospital associated infections through reduced frequency of change in dressings during treatment. This directly translates to a decrease in the unit cost in contrast to the traditional method of wound cleansing and tending...

  The   Peripheral Intravenous Catheter Market   is to grow at a   CAGR of 7%   between   2019 to 2029   and reach   US$ US$ 4.9 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 202...

  The   Peripheral Intravenous Catheter Market   is to grow at a   CAGR of 7%   between   2019 to 2029   and reach   US$ US$ 4.9 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 202...

  The   Peripheral Intravenous Catheter Market   is to grow at a   CAGR of 7%   between   2019 to 2029   and reach   US$ US$ 4.9 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 202...

  The   Mammalian Cell Banking Market   is to grow at a   CAGR of 14.1%   between   2020 to 2030   and reach   US$ US$ 1.1 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Cell banks allow the storage and generation of detailed characterizations of cell lines with specific genomes for research use. Mammalian cells are mostly used in the biopharmaceutical industry for the production of recombinant therapeutic proteins. Moreover, mammalian cell lines are used as host cells for the production of biologics in the biopharmaceutical industry. The  mammalian cell banking market  is expanding with increasing cancer research. Companies are channelizing efforts to maximize...

  The   Peripheral Intravenous Catheter Market   is to grow at a   CAGR of 7%   between   2019 to 2029   and reach   US$ US$ 4.9 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 202...

  The   Pulmonary Fibrosis Treatment Market   is to grow at a   CAGR of 6.2%   between   2021-2031   and reach   US$ US$ 2.7 Bn . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Monotherapy is cost-effective and gives deliverable action directly to the site of action in a few minutes, and is said to be a safe and effective method for treating idiopathic pulmonary fibrosis (IPF). According to Persistence Market Research (PMR), request for pulmonary fibrosis treatment is predicted to increase, enabling the market to surpass US$ 2.7 Bn by 2021. Over the coming years, rising cases of IPF will support the expansion of the market. Get Sample Copy of Report @  https://www.persistence...

  The   Peripheral Intravenous Catheter Market   is to grow at a   CAGR of 7%   between   2019 to 2029   and reach   US$ US$ 4.9 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at  US$ 4.9 Bn  in  2020 , and is expected to witness a healthy  CAGR of 7%  during the forecast period ( 202...

  The   Medical Spas Market   is to grow at a   CAGR of 15.4%   between   2021-2031   and reach   US$ US$ 30 Bn . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Prevalence of skin diseases is constantly on the rise, globally. This is constructing major health encumbrance on most economies. A healthcare facility that is supervised by a licensed healthcare provider, full time, is termed as a medical spa. The objective of the industry is to offer medical education and care in a setting that includes spa facilities as well as conventional, complementary, and/or alternative therapies and treatments. Botox injections, anti-wrinkle and fine line reduction therapies, acne surgery, and fil...

  The   Allergy Shots Market   is to grow at a   CAGR of 6.12%   between   2020 to 2030   and reach   US$ US$ 1.5 Billion . The healthcare vertical is moving towards consumerism, as the healthcare consumers in the present scenario happen to be techno-savvy, frugal, and looking for convenience. Also, personalization has taken the centre stage. With this agenda, healthcare solutions are bound to act as personalized caregivers going forward. Allergy shots, also known as allergy immunotherapies, including subcutaneous immunotherapy, sublingual immunotherapy, and oral therapies, is a long-term treatment that helps reduce allergic reactions. The most common type of allergy includes allergic rhinitis/hay fever, which accounts for  43%  of the cases. According to a latest report published by the PMR, the global allergy shots market is projected to be valued at  US$ 1.5 Bn  in  2020 , and is expected to expand at a CAGR o...